Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa-Reference-Cited by-同舟云学术

Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa

Published:2019-01-10 Issue:2 Volume:380 Page:121-131
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Tshilolo Léon¹^ORCID,Tomlinson George¹^ORCID,Williams Thomas N.¹^ORCID,Santos Brígida¹,Olupot-Olupot Peter¹,Lane Adam¹,Aygun Banu¹,Stuber Susan E.¹,Latham Teresa S.¹,McGann Patrick T.¹^ORCID,Ware Russell E.¹^ORCID

Affiliation:

1. From Centre Hospitalier Monkole, Kinshasa, Democratic Republic of Congo (L.T.); the Department of Medicine, University Health Network and Mt. Sinai Hospital, and the University of Toronto, Toronto (G.T.); the Kenya Medical Research Institute (KEMRI)–Wellcome Trust Research Program, Kilifi, Kenya (T.N.W.); the Department of Medicine, Imperial College London, London (T.N.W.); Hospital Pediátrico David Bernardino, Luanda, Angola (B.S.); Mbale Clinical Research Institute and Mbale Regional Referral and...

Funder

National Heart, Lung, and Blood Institute

Cincinnati Children’s Research Foundation

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1813598

Cited by 220 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sickle-Cell Diseases;International Encyclopedia of Public Health;2025

2. Consensus-driven target product profiles for curative sickle cell disease gene therapies;Molecular Therapy - Methods & Clinical Development;2024-09

3. Hydroxyurea in the sickle cell disease modern era;Expert Review of Clinical Pharmacology;2024-08-20

4. Hydroxyurea mobile directly observed therapy versus standard monitoring in patients with sickle cell anemia: a phase 2 randomized trial;Communications Medicine;2024-08-09

5. Current and emerging drug treatment strategies to tackle sickle cell anemia;Expert Opinion on Emerging Drugs;2024-07-22